KEGG   DRUG: Haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Entry
D09189                      Drug                                   
Name
Haemophilus b conjugate vaccine (tetanus toxoid conjugate);
Haemophilus influenzae type b conjugate vaccine;
Acthib (TN);
Hiberix (TN)
Product
ACTHIB (Sanofi Pasteur), HIBERIX (GlaxoSmithKline Biologicals SA)
Remark
Therapeutic category: 6311
ATC code: J07AG51
Product: D09189<JP/US>
Efficacy
Antiviral, Active immunization
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07A BACTERIAL VACCINES
    J07AG Haemophilus influenzae b vaccines
     J07AG51 Haemophilus influenzae b, combinations with toxoids
      D09189  Haemophilus b conjugate vaccine (tetanus toxoid conjugate) <JP/US>
USP drug classification [BR:br08302]
 Immunological Agents
  Vaccines
   Haemophilus Influenzae Type B (Hib)
    Haemophilus influenzae Type B Vaccine, PRP-T Conjugate
     D09189  Haemophilus b conjugate vaccine (tetanus toxoid conjugate)
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6311  Bacterial vaccines
     D09189  Haemophilus b conjugate vaccine (tetanus toxoid conjugate)
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D09189
Other DBs
PubChem: 96025869
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system